Susquehanna Fundamental Investments, LLC Vericel Corp Transaction History

Susquehanna Fundamental Investments, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$32.52 - $52.33 $619,115 - $996,258	19,038 New	19,038 $990 Million
Q3 2023 Nov 14, 2023	SELL	$31.69 - $39.25 $255,294 - $316,198	-8,056 Reduced 40.74%	11,720 $392,000
Q1 2023 May 16, 2023	SELL	$23.85 - $31.34 $203,225 - $267,048	-8,521 Reduced 30.11%	19,776 $579,000
Q4 2022 Feb 14, 2023	SELL	$17.65 - $27.37 $369,996 - $573,757	-20,963 Reduced 42.56%	28,297 $745,000
Q3 2022 Nov 14, 2022	BUY	$22.62 - $32.54 $911,812 - $1.31 Million	40,310 Added 450.39%	49,260 $1.14 Million
Q1 2022 May 16, 2022	BUY	$31.69 - $43.29 $283,625 - $387,445	8,950 New	8,950 $342,000

276

48.5M

91.8K

23.2K

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.67B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.